ESC 365 - Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation

Back

EHRA Premium Access

Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - Discussion

Session: Late-breaking trials 1

Topic: Rhythm Control, Catheter Ablation

Speaker: Professor J. Merino (Madrid, ES)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Professor Jose Luis Merino

La Paz University Hospital, Madrid (Spain)

44 presentations

16 followers

10 more presentations in this session

A randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation:The CIRCA-DOSE Study

Speaker: Doctor J. Andrade (Vancouver, CA)

Access

Slides

Video

CIRCA-DOSE Study - Discussion

Speaker: Professor D. Scherr (Graz, AT)

Access

Slides

Video

Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - AVATAR AF

Speaker: Professor P. Kanagaratnam (London, GB)

Access

Slides

Video

Quality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation catheter: results from the multicenter GOLD AF registry

Speaker: Professor L. Boersma (Nieuwegein, NL)

Access

Slides

Video

GOLD AF registry - Discussion

Access

Slides

Video

Access the full session

Late-breaking trials 1

Speakers: Professor J. Merino, Doctor J. Andrade, Professor D. Scherr, Professor P. Kanagaratnam, Professor L. Boersma

Access

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources